Dosage regime claims in the European Patent Office

Sigrid Sterckx

Research output: Contribution to journalArticle


This article presents the main arguments put forward in a hearing before the highest instance of the European Patent Office (the Enlarged Board of Appeal) regarding the patentability of dosage regimes for pharmaceuticals.
Original languageEnglish
Pages (from-to)294-298
Number of pages5
JournalEuropean Intellectual Property Review
Publication statusPublished - 15 Feb 2010


  • patentability
  • dosage regimes
  • pharmaceuticals
  • Europe


Dive into the research topics of 'Dosage regime claims in the European Patent Office'. Together they form a unique fingerprint.

Cite this